Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) independent director
Independent opinions on the extension of some investment projects with raised funds
In accordance with the guiding opinions on the establishment of independent director system in listed companies, the Listing Rules of Shanghai Stock Exchange and other laws, regulations and normative documents, as well as the articles of association of Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) , we, as independent directors of Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) (hereinafter referred to as the “company”), based on the principles of good faith, diligence and prudence, Carefully checked the proposal on the extension of some investment projects with raised funds submitted at the 18th meeting of the Fourth Board of directors, and made the following independent opinions based on independent judgment:
The company’s postponement of some raised capital investment projects (hereinafter referred to as “raised capital investment projects”) does not involve changes in the implementation subject, investment content, investment purpose, etc., does not affect the implementation of raised capital investment projects and the company’s normal production and operation, and does not change the purpose of raised capital in a disguised manner and damage the interests of shareholders, It complies with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies and the measures for the management of raised funds by listed companies of Shanghai Stock Exchange (revised in 2013) issued by the China Securities Regulatory Commission, and has fulfilled the necessary decision-making procedures.
Therefore, we unanimously agree on the extension of the company’s raised investment project.
Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) independent directors: Chen, Chuan, Zhong LIUCai, Chen Jianfei, January 21, 2002
